Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Senseonics Holdings, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0.33
6.37
18.9
21.3
4.95
13.7
16.4
22.4
22.5
35.3
Cost of revenue
0.66
9.76
27.1
40.7
22.3
14.5
13.7
19.3
21.9
19.5
Gross profit
-0.33
-3.39
-8.15
-19.4
-17.4
-0.81
2.73
3.09
0.53
15.8
Research and development
26.3
30.7
31.9
38.4
20.4
27.2
39.7
48.8
41.1
31.6
Selling, general and administrative
41.4
29.2
31.6
29.9
34.2
52.5
Selling and marketing
2.74
6.86
27.7
49.6
20.6
5.48
General and administrative
13
15.3
19.8
23.2
20.8
21.5
Operating income
-42.4
-56.3
-87.6
-131
-79.1
-57.2
-68.6
-75.6
-74.8
-68.3
Interest expense
1.6
3.1
8.28
11.8
16.2
16.7
18.7
11.1
8.44
4.95
Interest income
0.08
0.14
2
1.93
0.18
0.24
1.82
5.36
4.5
4.2
Other non-operating income
-1.5
-2.79
-6.39
15.1
-96
-245
211
15.2
-3.77
-0.78
Pre-tax income
-78.6
-69.1
Income tax
0
0
0
0
0
0
0
0
0
Net income
-43.9
-59.1
-94
-116
-175
-302
142
-60.4
-78.6
-69.1
EBITDA
-42.3
-56.1
-87.3
-130
-78
-55.9
-67.6
-74.3
-73.4
-66.8
EPS, basic
-10.21
-10.63
-12.50
-12.71
-16.04
-15.00
6.25
-2.29
-2.50
-1.66
EPS, diluted
-10.21
-10.63
-12.50
-12.71
-16.04
-15.00
-2.29
-2.29
-2.50
-1.66
Shares, basic (weighted)
4.28
5.57
7.56
9.06
10.9
20.3
22.5
27.3
31.5
41.7
Shares, diluted (weighted)
4.28
5.57
7.56
9.06
10.9
20.3
29.7
27.3
31.5
41.7
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
13
16.2
137
95.9
18
33.5
35.8
75.7
74.6
40.2
Short-term investments
7.29
20.3
0
96.4
108
33.7
0
53.8
Receivables
6.29
12.1
Inventory
0.48
2.99
10.2
16.9
5.28
6.32
7.31
8.78
4.42
6.7
Other current assets
0.06
0.05
3.99
4.51
3.77
6.22
7.43
7.27
5.82
4.37
Total current assets
21.4
44.9
158
128
30.2
144
161
130
91.4
118
Property, plant and equipment
0.74
0.85
1.75
2
1.56
1.31
1.11
1.18
Lease right-of-use assets
2.82
2.13
0.82
3.03
5.18
4.84
4.46
Intangible assets
0.6
Long-term investments
51.9
12.3
Total assets
22.3
45.9
160
133
35.9
199
178
138
100
126
Accounts payable
3.07
7.71
4.41
4.29
1.76
1.2
0.42
4.57
3.21
4.06
Accrued liabilities
4.48
2.21
3.69
5.63
4.34
3.48
4.7
4.8
5.31
5.27
Deferred revenue
0.63
Total current liabilities
11.6
23.1
28.9
127
16.6
18.4
31.5
17.3
38.8
24.3
Long-term debt
15.2
14.4
4.78
Lease liabilities
2.28
1.48
0.58
2.69
6.21
5.79
5.29
Other non-current liabilities
0.07
0.07
1.85
2.28
1.48
0.58
2.69
6.21
5.79
Total liabilities
27.1
38.7
88.7
141
177
384
143
64.8
79.3
65.2
Total debt
11.8
57.2
59.8
56.4
41.2
34.7
35.6
Paid-in capital
200
271
429
464
504
765
806
905
931
1,078
Retained earnings
-205
-264
-358
-473
-649
-951
-809
-869
-948
-1,017
Treasury stock
0
Other comprehensive income
-0.21
-0.68
-0.01
0.07
Shareholders' equity
-4.88
7.27
71.3
-8.65
-144
-186
-2.58
35.8
-16.6
61
Total equity
-4.88
7.27
71.3
-8.65
-144
-186
-2.58
35.8
-16.6
61
Total liabilities and equity
22.3
45.9
160
133
35.9
199
178
138
100
126
Shares outstanding
4.49
6.57
8.49
9.77
12.7
21.5
23
25.5
29.8
41.3
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-43.9
-59.1
-94
-116
-175
-302
142
-60.4
-78.6
-69.1
Depreciation and amortization
0.16
0.23
0.27
1
1.14
1.24
0.99
1.28
1.48
1.51
Stock-based compensation
2.42
3.99
6.41
8.05
7.31
9.03
8.62
8.67
9.23
10.2
Change in receivables
-0.25
-3.13
-3.72
-3.28
7.39
1.01
-0.48
-2.19
-2.7
-6.77
Change in inventory
-0.48
-2.74
-7.44
-6.7
11.6
-1.04
-0.99
-1.64
0.7
-2.98
Change in payables
1.82
4.64
-3.4
-0.12
-2.52
-0.56
-0.79
2.3
-1.83
1.22
Cash from operations
-38
-55.7
-90.8
-136
-67.4
-56.1
-66.3
-70.2
-60.5
-59.1
Capital expenditures
-0.48
-0.35
-0.99
-1.05
-0.18
-0.21
-0.31
-0.35
-2.24
-1.12
Purchases of investments
-7.29
-33.2
-7.94
-155
-105
-68.5
-58
-101
Sales and maturities of investments
20.3
28.4
5.98
132
159
93.1
48.4
Cash from investing
-7.77
-13.2
19.4
-1.05
-0.18
-149
26.9
89.7
32.8
-53.4
Debt issued
53
127
56
Stock issued
46.2
67.6
150
28.8
Cash from financing
54.9
72.1
192
96.2
-10.1
220
41.8
20.4
26.8
78.2
Net change in cash
9.11
3.1
121
-40.9
-77.7
15.3
2.33
39.9
-0.8
-34.4
Free cash flow
-38.5
-56.1
-91.8
-137
-67.6
-56.3
-66.6
-70.5
-62.7
-60.2
Interest paid
0.89
1.83
3.14
5.23
4.73
7.82
6.57
3.68
4.51
4.05
Income taxes paid
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $10.00 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
54.9%
Gross profit / revenue.
Operating margin
-223.2%
Operating income / revenue.
EBITDA margin
-219.4%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-225.3%
Net income / revenue.
FCF margin
-199.5%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-197.6%
Cash from operations / revenue.
Return on equity (ROE)
-121.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-61.9%
Net income / average total assets.
Return on invested capital (ROIC)
-84.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
75.9%
Research and development expense / revenue.
SG&A / revenue
202.2%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
23.2%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.8%
Capital expenditures / revenue.
D&A / revenue
3.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
56.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
29.1%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
48.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
2,857.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
79.5%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
25.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-10.8%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
28.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
32.5%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
12.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
30.7%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
6.74x
Current assets / current liabilities.
Quick ratio
6.20x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
5.78x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.62x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
31.6%
Total debt / total assets.
Liabilities / assets
48.9%
Total liabilities / total assets.
Net debt
-$86.9M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.89
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.84
Revenue / diluted weighted shares.
FCF per share
-$1.67
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$1.66
Cash from operations / diluted weighted shares.
Book value per share
$1.71
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
10.9x
Market cap / revenue.
P/B
5.85x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
5.85x
Market cap / tangible book value, when positive.
EV/Sales
9.10x
Enterprise value / revenue.
FCF yield
-18.3%
Free cash flow / market cap.
Earnings yield
-20.7%
Net income / market cap (the inverse of P/E).
What was Senseonics Holdings, Inc.'s revenue in fiscal 2025?
Senseonics Holdings, Inc. reported revenue of $35.3M for fiscal 2025, 56.9% higher than the year before.
Was Senseonics Holdings, Inc. profitable in fiscal 2025?
No. It reported a net loss of $69.1M.
How much free cash flow did Senseonics Holdings, Inc. generate in fiscal 2025?
Cash from operations of $59.1M minus capital expenditures of $1.1M left free cash flow of -$60.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.